Meribank Biotech Co Stock

Meribank Biotech Co P/B

The P/B (Price-to-Book Ratio) of Meribank Biotech Co (4724.TWO) as of Aug 26, 2026 is 1.02. In the previous year, P/B (Price-to-Book Ratio) was 1.06 — a change of -3.48% (lower).

P/B

1.02

YoY

-3.48%

Last updated:

P/B (Price-to-Book Ratio) of Meribank Biotech Co is 2026 1.02 . P/B (Price-to-Book Ratio) of Meribank Biotech Co was 2025 1.06 . It decreases by -3.48% lower compared to the previous year.

The Meribank Biotech Co P/B history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

P/B
Date
P/B
Jan 1, 2019
2.94 TWD
Jan 1, 2020
3.34 TWD
Jan 1, 2021
2.18 TWD
Jan 1, 2022
2.71 TWD
Jan 1, 2023
1.93 TWD
Jan 1, 2024
1.06 TWD
Jan 1, 2025
1.02 TWD
The Meribank Biotech Co P/B history
YEARP/BYoY
1.02-3.48%
1.06-45.12%
1.93-28.79%
2.71+24.37%
2.18-34.71%
3.34+13.52%
2.94
Access this data via the Eulerpool API

Meribank Biotech Co Stock analysis

What does Meribank Biotech Co do? Meribank Biotech Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Meribank Biotech Co stock

P/B (Price-to-Book Ratio) of Meribank Biotech Co is 1.02 in 2026.

P/B (Price-to-Book Ratio) of Meribank Biotech Co changed from 1.06 to 1.02, representing a -3.48% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of P/B (Price-to-Book Ratio) Meribank Biotech Co since 2006 – with annual values, charts, and detailed analysis.

The Price-to-Book ratio compares a company's market price to its book value. A low P/B may indicate an undervalued stock, while a high P/B could suggest overvaluation or strong growth expectations.

P/B = Stock Price / Book Value per Share

To evaluate P/B (Price-to-Book Ratio)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for P/B (Price-to-Book Ratio).

A 'good' varies by industry and company stage. On Eulerpool, you can compare P/B (Price-to-Book Ratio)'s Meribank Biotech Co with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

Valuation — Meribank Biotech Co

All Key Metrics — Meribank Biotech Co